- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Anthem Blue Cross and Blue Shield and Yale New Haven Health System Reach a New Multi-Year Agreement
Anthem Blue Cross and Blue Shield and Yale New Haven Health System announced today that they have reached a new multi-year agreement that will maintain Yale New Haven Health System’s physicians and hospitals in Anthem’s network.
WALLINGFORD and NEW HAVEN, CT – Anthem Blue Cross and Blue Shield and Yale New Haven Health System announced today that they have reached a new multi-year agreement that will maintain Yale New Haven Health System’s physicians and hospitals in Anthem’s network.
“At a time when prioritizing the health of our communities is more important than ever, we are very pleased to have reached this agreement, which protects affordability for consumers and ensures our members continue to have access to quality care at Yale New Haven Health System. We value our partnership with Yale as we work together to tackle the COVID-19 pandemic and improve lives and communities here in Connecticut,” said Jill Hummel, President of Anthem Blue Cross and Blue Shield in Connecticut.
Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025
July 18th 2025These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.
Read More
From Red Tape to Relief: Rewriting the Rules of Prior Authorization
June 23rd 2025Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.
Read More
Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD
June 19th 2025Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan, PhD, Cleveland Clinic.
Read More
